Crossmark

A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form

Crossref DOI link: https://doi.org/10.1186/s43094-020-00060-y

Published Online: 2020-07-28

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noorbasha, Khaleel https://orcid.org/0000-0001-9713-5558
Nurbhasha, Sharmila
License Information

Text and Data Mining valid from 2020-07-28

Version of Record valid from 2020-07-28
More Information

Article History

Received: 28 March 2020

Accepted: 20 July 2020

First Online: 28 July 2020

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below